Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

格隆汇6月23日｜研究显示，患者在使用诺和诺德减肥药Wegovy的同时，联合服用礼来的实验性药物bimagrumab，在减重的同时能够有效保持肌肉质量。据周一在芝加哥举行的美国糖尿病协会年会公布的结果，联合用药的患者在48周内体重下降了22.1%，其中92.8%为体脂减少。值得注意的是，bimagrumab单药组减去的100%体重均来自脂肪，且瘦体重增加了2.5%。

Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

Novo Nordisk ended a short-lived agreement to sell its Wegovy weight-loss drug through Hims & Hers Health on Monday, sending ...

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing ...

Hims & Hers stock drops after Wegovy manufacturer ends deal to distribute weight loss drug - Hims & Hers had partnered with ...

Novo Nordisk has terminated its partnership with Hims & Hers Health for the distribution of its Wegovy weight-loss drug, ...

While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...